RT @JeremyMen2: @Immutep @Merck don't wait eftilagimod is the future....it will be used in all major applications with zero toxicity 3 bill…
4 followers
438 followers
RT @jitcancer: ICYMI - LAG-3: from molecular functions to clinical applications (part of the #JITC review series on Immune Checkpoints Beyo…
8,083 followers
ICYMI - LAG-3: from molecular functions to clinical applications (part of the #JITC review series on Immune Checkpoints Beyond PD-1) https://t.co/cqJ6BO5PHE https://t.co/jvAtJd2Pe8
516 followers
RT @jitcancer: Start your #ASCO22 morning with this popular review from Taku Okazaki's group at The University of Tokyo - part of the #JITC…